BREAKING: FDA Fast Tracks Self-Amplifying mRNA Bird Flu Injection
In November 2024, the FDA green-lit a Phase 1 trial for the Arcturus Therapeutics self-amplifying (replicon) H5N1 “pandemic” bird flu injection (ARCT-2304):
These experimental replicon shots are primarily funded by BARDA with support from the Gates Foundation, who gave Arcturus Therapeutics a $928,563 grant in October 2024 to “improve understanding of durability of protection after administration of nucleic-acid based vaccines.”
Yesterday, Arcturus Therapeutics received U.S. FDA Fast Track Designation for the replicon injection ARCT-2304:
Read More: BREAKING: FDA Fast Tracks Self-Amplifying mRNA Bird Flu Injection
***
This article has been archived by Conspiracy Resource for your research. The original version from David Icke can be found here.
